Neoplasms Of Uncertain Behavior ICD 9 Codes (235-238)

NEOPLASMS OF UNCERTAIN BEHAVIOR (ICD 9 CODES: 235-238)

Note:    Categories 235-238 classify by site certain histo-morphologically well-defined neoplasms, the subsequent behavior of which cannot be predicted from the present appearance.

235 Neoplasm of uncertain behavior of digestive and respiratory systems

Excludes:    stromal tumors of uncertain behavior of digestive system (238.1)

235.0    Major salivary glands

Gland:

parotid

sublingual

submandibular

Excludes: minor salivary glands (235.1)

235.1    Lip, oral cavity, and pharynx

Gingiva

Hypopharynx

Minor salivary glands

Mouth

Nasopharynx

Oropharynx

Tongue

Excludes: aryepiglottic fold or interarytenoid fold, laryngeal aspect (235.6)

epiglottis:

NOS (235.6)

suprahyoid portion (235.6)

skin of lip (238.2)

235.2    Stomach, intestines, and rectum

235.3    Liver and biliary passages

Ampulla of Vater

Bile ducts [any]

Gallbladder

Liver

235.4    Retroperitoneum and peritoneum

235.5    Other and unspecified digestive organs

Anal:

canal

sphincter

Anus NOS

Esophagus

Pancreas

Spleen

Excludes: anus:

margin (238.2)

skin (238.2)

perianal skin (238.2)

235.6    Larynx

Excludes: aryepiglottic fold or interarytenoid fold:

NOS (235.1)

hypopharyngeal aspect (235.1)

marginal zone (235.1)

235.7    Trachea, bronchus, and lung

235.8    Pleura, thymus, and mediastinum

235.9    Other and unspecified respiratory organs

Accessory sinuses

Middle ear

Nasal cavities

Respiratory organ NOS

Excludes: ear (external) (skin) (238.2)

nose (238.8)

skin (238.2)

236       Neoplasm of uncertain behavior of genitourinary organs

236.0    Uterus

236.1    Placenta

Chorioadenoma (destruens)

Invasive mole

Malignant hydatid mole

Malignant hydatidiform mole

236.2    Ovary

Use additional code to identify any functional activity

236.3    Other and unspecified female genital organs

236.4    Testis

Use additional code to identify any functional activity

236.5    Prostate

236.6    Other and unspecified male genital organs

236.7    Bladder

236.9    Other and unspecified urinary organs

236.90  Urinary organ, unspecified

236.91  Kidney and ureter

236.99  Other

237       Neoplasm of uncertain behavior of endocrine glands and nervous system

237.0    Pituitary gland and craniopharyngeal duct

Use additional code to identify any functional activity

237.1    Pineal gland

237.2    Adrenal gland

Suprarenal gland

Use additional code to identify any functional activity

237.3    Paraganglia

Aortic body

Carotid body

Coccygeal body

Glomus jugulare

237.4    Other and unspecified endocrine glands

Parathyroid gland

Thyroid gland

237.5    Brain and spinal cord

237.6    Meninges

Meninges:

NOS

cerebral

spinal

237.7    Neurofibromatosis

237.70  Neurofibromatosis, unspecified

237.71  Neurofibromatosis, type 1 [von Recklinghausen's disease]

237.72  Neurofibromatosis, type 2 [acoustic neurofibromatosis]

237.73  Schwannomatosis

237.79  Other neurofibromatosis

237.9    Other and unspecified parts of nervous system

Cranial nerves

Excludes: peripheral, sympathetic, and parasympathetic nerves and ganglia (238.1)

238       Neoplasm of uncertain behavior of other and unspecified sites and tissues

238.0    Bone and articular cartilage

Excludes: cartilage:

ear (238.1)

eyelid (238.1)

larynx (235.6)

nose (235.9)

synovia (238.1)

238.1    Connective and other soft tissue

Peripheral, sympathetic, and parasympathetic nerves and ganglia

Stromal tumors of digestive system

Excludes: cartilage (of):

articular (238.0)

larynx (235.6)

nose (235.9)

connective tissue of breast (238.3)

238.2    Skin

Excludes: anus NOS (235.5)

skin of genital organs (236.3, 236.6)

vermilion border of lip (235.1)

238.3    Breast

Excludes: skin of breast (238.2)

238.4    Polycythemia vera

238.5    Histiocytic and mast cells

Mast cell tumor NOS

Mastocytoma NOS

238.6    Plasma cells

Plasmacytoma NOS

Solitary myeloma

238.7    Other lymphatic and hematopoietic tissues

Excludes: acute myelogenous leukemia (205.0)

chronic myelomonocytic leukemia (205.1)

myelosclerosis NOS (289.89)

myelosis:

NOS (205.9)

megakaryocytic (207.2)

238.71  Essential thrombocythemia

Essential hemorrhagic thrombocythemia

Essential thrombocytosis

Idiopathic (hemorrhagic) thrombocythemia

Primary thrombocytosis

238.72  Low grade myelodysplastic syndrome lesions

Refractory anemia (RA)

Refractory anemia with excess blasts-1 (RAEB-1)

Refractory anemia with ringed sideroblasts (RARS)

Refractory cytopenia with multilineage dysplasia (RCMD)

Refractory cytopenia with multilineage dysplasia and ringed sideroblasts (RCMD-RS)

238.73  High grade myelodysplastic syndrome lesions

Refractory anemia with excess blasts-2 (RAEB-2)

238.74  Myelodysplastic syndrome with 5q deletion

5q minus syndrome NOS

Excludes: constitutional 5q deletion (758.39)

high grade myelodysplastic syndrome with 5q deletion (238.73)

238.75  Myelodysplastic syndrome, unspecified

238.76  Myelofibrosis with myeloid metaplasia

Agnogenic myeloid metaplasia

Idiopathic myelofibrosis (chronic)

Myelosclerosis with myeloid metaplasia

Primary myelofibrosis

Excludes: myelofibrosis NOS (289.83)

myelophthisic anemia (284.2)

myelophthisis (284.2)

secondary myelofibrosis (289.83)

238.77  Post-transplant lymphoproliferative disorder (PTLD)

Code first complications of transplant (996.80-996.89)

238.79  Other lymphatic and hematopoietic tissues

Lymphoproliferative disease (chronic) NOS

Megakaryocytic myelosclerosis

Myeloproliferative disease (chronic) NOS

Panmyelosis (acute)

238.8    Other specified sites

Eye

Heart

Excludes: eyelid (skin) (238.2)

cartilage (238.1)

238.9    Site unspecified